| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |